09995.HK
RemeGen Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 80.00
−1.48%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 8.87x
- P/E 2027E
- 41.86x
- P/E 2028E
- 24.81x
- P/S forward
- 6.87x
Trailing multiples
Trailing twelve months
- P/E TTM
- 6.61x
- PEG TTM
- —
- Price / book
- 4.61x
- Price / sales
- 4.82x
- Price / cash flow
- 8.52x
Enterprise value
- Enterprise value
- HKD 39.1B
- EV / sales
- 4.22x
- EV / EBITDA
- 6.59x
- EV / EBIT
- 6.90x
- Market cap
- HKD 44.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026